Shots:

• The first patient has been enrolled in the (Expand URO) US clinical trial evaluating the safety & performance of the Hugo RAS system in 122 patients for urologic procedures incl. radical prostatectomy, radical cystectomy & nephrectomy procedures at 6 sites across the US
• The system is commercially available in certain geographies. The Hugo RAS system's market availability & approved indications will be determined by regulatory requirements and status in various nations & regions
• Hugo combines with Medtronic’s Touch Surgery Enterprise to provide a smart, digitally enable surgical experience. In hospitals on 3 different continents, the Hugo RAS system is used for a variety of urology, gynaecology & general surgery procedures outside the US

Ref: Medtronic | Image: Medtronic